Lab
KPC Biotech, INC
KPC Biotech, INC was paid $755K by Medicaid between Feb 2023 and Nov 2024, across 21 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 52% of everything it billed.
33Billing provider infoKPC BIOTECH, INC
HEMET, CA 92543
HEMET, CA 92543
33aNPI1538815089assigned 02/23/2022
33bProvider typeClinical Medical Laboratory
28Total paid$755K
24GClaims13,466
24DCodes billed21
24AFirst – last monthFeb 2023 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#208 of 561
Median peer was paid$222K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 3,273 | $202K | |
| 2024incomplete | 10,193 | $553K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 52% | 2,118 | 2,076 | $391K |
| 87481 | 13% | 796 | 789 | $97K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.0% | 1,815 | 1,783 | $38K |
| 87631 | 3.3% | 700 | 671 | $25K | |
| 87653 | 3.3% | 1,144 | 1,133 | $25K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.2% | 578 | 575 | $24K |
| 87640 | 3.0% | 949 | 934 | $23K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.1% | 579 | 576 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.1% | 555 | 546 | $16K |
| 87563 | 2.1% | 434 | 431 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 557 | 549 | $15K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 500 | 495 | $14K |
9 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARUSO, DAWN (CEO)